[An experimental study on the regulation of bone marrow-derived mesenchymal stem cells through indoleamine 2,3-dioxygenase signaling pathway by thymosin α1 for improving the immunosuppression mediated by T cell].

Zhonghua er ke za zhi. Chinese journal of pediatrics

Volumn 49, Issue 3, 2011, Pages 181-185

  Hou, Fang ^a   Huang, Jian Ming ^b   Zhang, Rong ^b   Li, Lan ^b   Li, G ^b  

^a SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; INDOLEAMINE 2,3 DIOXYGENASE; THYMOSIN; THYMOSIN ALPHA1; TLR9 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 9;

ADOLESCENT; APLASTIC ANEMIA; ARTICLE; BONE MARROW CELL; CASE CONTROL STUDY; CHILD; DRUG EFFECT; FEMALE; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MALE; MESENCHYMAL STEM CELL; METABOLISM; SIGNAL TRANSDUCTION;

ADOLESCENT; ANEMIA, APLASTIC; BONE MARROW CELLS; CASE-CONTROL STUDIES; CHILD; FEMALE; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; MALE; MESENCHYMAL STEM CELLS; SIGNAL TRANSDUCTION; THYMOSIN; TOLL-LIKE RECEPTOR 9;

EID: 80155123787     PISSN: 05781310     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)